erythromycin has been researched along with Sclerosis, Systemic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamasaki, Y; Hatamochi, A; Ikeda, H; Omura, S; Sunazuka, T; Suzuki, H; Yamazaki, S | 1 |
| Eaker, EY; Hardy, E; Sninsky, CA; Verne, GN | 1 |
| Bassotti, G; Betti, C; Chiucchiù, S; Distrutti, E; Fiorucci, S; Gerli, R; Morelli, A; Santucci, L | 1 |
| Distrutti, E; Fiorucci, S; Gerli, R; Morelli, A | 1 |
| Endres, SP; Folwaczny, C; König, A; Läritz, M; Meurer, M; Schindlbeck, N | 1 |
| Cavicchi, M; Delchier, JC; Lecomte, T | 1 |
| Dull, JS; Raufman, JP; Strashun, A; Straus, EW; Zakai, MD | 1 |
| Markalous, E; Paukert, H | 1 |
1 trial(s) available for erythromycin and Sclerosis, Systemic
| Article | Year |
|---|---|
Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.
Topics: Adult; Aged; Aged, 80 and over; Eating; Erythromycin; Fasting; Female; Gallbladder Emptying; Gastrointestinal Motility; Humans; Male; Manometry; Middle Aged; Scleroderma, Systemic; Ultrasonography | 1994 |
7 other study(ies) available for erythromycin and Sclerosis, Systemic
| Article | Year |
|---|---|
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
Topics: Adult; Anti-Bacterial Agents; CCAAT-Binding Factor; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Erythromycin; Female; Fibroblasts; Humans; Infant; Male; Middle Aged; Promoter Regions, Genetic; RNA, Messenger; Scleroderma, Systemic; Transcription, Genetic | 2008 |
Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Intestinal Pseudo-Obstruction; Male; Manometry; Middle Aged; Octreotide; Prospective Studies; Scleroderma, Systemic | 1995 |
Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
Topics: Drug Administration Schedule; Erythromycin; Female; Gallbladder Emptying; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Male; Middle Aged; Motilin; Scleroderma, Systemic; Stimulation, Chemical; Time Factors | 1994 |
[Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Topics: Aged; Cisapride; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Middle Aged; Octreotide; Piperidines; Scleroderma, Systemic; Sympathomimetics; Treatment Outcome | 1997 |
[Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
Topics: Antibodies, Antinuclear; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Humans; Intestinal Pseudo-Obstruction; Intestine, Small; Long-Term Care; Male; Middle Aged; Octreotide; Recurrence; Scleroderma, Systemic; Time Factors; Treatment Outcome | 2000 |
Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis.
Topics: Adult; Erythromycin; Female; Gastric Emptying; Humans; Infusions, Intravenous; Scleroderma, Systemic; Single-Blind Method; Stomach Diseases; Time Factors | 1990 |
[New therapy of dermatomyositis and scleroderma].
Topics: Adult; Anti-Bacterial Agents; Dermatomyositis; Erythromycin; Female; Humans; Oxytetracycline; Scleroderma, Systemic; Vasodilator Agents | 1967 |